AI assistant
AbbVie Inc. — Director's Dealing 2015
Dec 11, 2015
29755_dirs_2015-12-11_41146fbe-49d3-4821-ad68-4ff2c23c43e0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2015-12-09
Reporting Person: Gosebruch Henry O (Chief Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-09 | Common stock, $0.01 par value | A | 26510 | — | Acquired | 26510 | Direct |
| 2015-12-09 | Common stock, $0.01 par value | A | 64540 | — | Acquired | 91050 | Direct |
Footnotes
F1: Performance vested restricted stock granted under the AbbVie 2013 Incentive Stock Program. The award has a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The award includes the right to have stock withheld for tax purposes.
F2: A retention award of restricted stock granted under the AbbVie 2013 Incentive Stock Program. The award vests in annual increments of 21,514 on 12/09/2016, 21,513 on 12/09/2017, and 21,513 on 12/09/2018. The award includes the right to have stock withheld for tax purposes.